Taro drops Plan to invest inSuzlon’s us power energy

Posted · Add Comment

solar-k8YG--621x414@LiveMint

Taro Pharmaceutical Industries, a global subsidiary of India’s largest drug maker Sun PharmaceuticalBSE -1.50 %, has dropped its plan to invest in a wind power project in the United States just four days after announcing the $250-million investment.

Taro, which is listed on the New York Stock Exchange, revealed its decision in a notification to the Securities Exchange Commission.

On Tuesday, Sun Pharma too, in a statement to the Bombay Stock Exchange, said, “Subsequent to  ..

Source:http://economictimes.indiatimes.com/markets/stocks/news/taro-pharma-drops-plan-to-invest-in-suzlons-us-power-project/articleshow/49914342.cms

Leave a Reply

Your email address will not be published. Required fields are marked *